Results 71 to 80 of about 575,429 (340)

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Performance Studies of Static Synchronous Compensator and Static Synchronous Series Compensator Modes for Convertible Static Compensator [PDF]

open access: yes, 2005
This thesis presents an overview of the emerging Flexible AC Transmission System (FACTS) and Convertible Static Compensator (CSC) technologies. CSC, the flexible multifunctional compensator is an innovation fi-om FACTS technology.
Abd Halim, Wahidah
core   +1 more source

A Review on the Application of 3D Printing Technology in Radiotherapy for Breast Cancer

open access: yesJournal of Mazandaran University of Medical Sciences, 2020
Breast cancer is considered as one of the main causes of cancer death in women. Early diagnosis and treatment, especially by modern technologies play major roles in management of breast cancer.
Seyed Hamid Zoljalali Moghaddam   +4 more
doaj  

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Reinterpretation of PDD2 compensator embedded in position control for pneumatic stage

open access: yesJournal of Advanced Mechanical Design, Systems, and Manufacturing, 2019
PDD2 (proportional + derivative + second derivative) compensator has been standardly used for position control of the pneumatic stage. This compensator is based on the integral characteristics of a pneumatic system composed of pipes, servo valves, and ...
Hiroki ISHII   +2 more
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Design, Implementation, and Control of a Ball-Balancing Robot

open access: yesIEEE Access
This paper presents the design, implementation, and control of a ball-balancing robot developed for interactive applications in service and entertainment environments.
Sangsin Park
doaj   +1 more source

Compensation conundrum

open access: yesPerspectives in Clinical Research, 2012
Pressured by questions tabled in parliament that point to a lack of adequate enforcement of regulations, the DCG(I) has abruptly initiated action to ensure payment of compensation for trial-related injuries. While it is astounding that non-compliance to the existing regulations could have gone unnoticed by quality assurance staff as well as by the ...
openaire   +3 more sources

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy